Statistical Thinking for Non-Statisticians in Drug Regulation - Image 1

£60.99

Wiley-Blackwell Statistical Thinking for Non-Statisticians in Drug Regulation

Name: Statistical Thinking for Non-Statisticians in Drug Regulation
Brand: Wiley-Blackwell
Price: 60.99 GBP
Availability: InStock

9781119867388

Pharmacy - Dispensing

Price History & Forecast

Last 1 days • 1 data points (No recent data available)

Historical

Generating forecast...

Not enough data points to display chart (need at least 2 points)

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price

Price Analysis

Most common price: £61 (1 days, 100.0%)

Price range: £61 - £61

Price levels: 1 different prices over 1 days

Description

STATISTICAL THINKING FOR NON-STATISTICIANS IN DRUG REGULATION Statistical methods in the pharmaceutical industry are accepted as a key element in the design and analysis of clinical studies. Increasingly, the medical and scientific community are aligning with the regulatory authorities and recognizing that correct statistical methodology is essential as the basis for valid conclusions. In order for those correct and robust methods to be successfully employed there needs to be effective communication across disciplines at all stages of the planning, conducting, analyzing and reporting of clinical studies associated with the development and evaluation of new drugs and devices. Statistical Thinking for Non-Statisticians in Drug Regulation provides a comprehensive in-depth guide to statistical methodology for pharmaceutical industry professionals, including physicians, investigators, medical science liaisons, clinical research scientists, medical writers, regulatory personnel, statistical programmers, senior data managers and those working in pharmacovigilance. The author’s years of experience and up-to-date familiarity with pharmaceutical regulations and statistical practice within the wider clinical community make this an essential guide for the those working in and with the industry. The third edition of Statistical Thinking for Non-Statisticians in Drug Regulation includes: A detailed new chapter on Estimands in line with the 2019 Addendum to ICH E9 Major new sections on topics including Combining Hierarchical Testing and Alpha Adjustment, Biosimilars, Restricted Mean Survival Time, Composite Endpoints and Cumulative Incidence Functions, Adjusting for Cross-Over in Oncology, Inverse Propensity Score Weighting, and Network Meta-Analysis Updated coverage of many existing topics to reflect new and revised guidance from regulatory authorities and author experience Statistical Thinking for Non-Statisticians in Drug Regulation is a valuable guide for pharmaceutical and medical device industry professionals, as well as statisticians joining the pharmaceutical industry and students and teachers of drug development.

Key Features

New Store Stock

Product Specifications

Brand: Wiley-Blackwell
Model: 9781119867388
Format: hardcover
ASIN: 111986738X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 29 December 2022
Listed Since: 01 June 2022

Barcode

No barcode data available

Wiley-Blackwell Statistical Thinking for Non-Statisticians in Drug Regulation

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Statistical Issues in Drug Development (Statistics in Practice)

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Statistical Remedies for Medical Researchers (Springer Series in Pharmaceutical Statistics)

Statistics in Medicine

Statistical Methods in Healthcare

Phase II Clinical Development of New Drugs (ICSA Book Series in Statistics)

Multiple Testing Problems in Pharmaceutical Statistics: 33 (Chapman & Hall/CRC Biostatistics Series)

Statistical Methods in Drug Combination Studies: 69 (Chapman & Hall/CRC Biostatistics Series)

Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

The Essentials of Biostatistics for Physicians, Nurses, and Clinicians

Basic Statistics and Pharmaceutical Statistical Applications (Pharmacy Education Series)

Success Probability Estimation with Applications to Clinical Trials

Causal Inference in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Encyclopedia of Biopharmaceutical Statistics - Four Volume Set

Contemporary Biostatistics with Biopharmaceutical Applications (ICSA Book Series in Statistics)

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Statistical Methods in Biomarker and Early Clinical Development

Wiley Medical Uses of Statistics, Third Edition (NEJM)

Design and Analysis of Clinical Trials: Concept and Methodologies (Wiley Series in Probability and Statistics)

Basic Statistics and Pharmaceutical Statistical Applications: 28 (Pharmacy Education Series)